For many years the Board of Pharmacy Specialties (BPS) had five recognized specialties (Nuclear Pharmacy — 1978, Nutrition Support — 1988, Pharmacotherapy — 1988, Psychiatric Pharmacy — 1992, and Oncology — 1996).
More than occasionally I am asked, by individuals who are sincere, yet uninformed, why healthcare needs a psychiatric pharmacy specialist or why the Board of Pharmacy Specialties (BPS) recognizes psychiatric as a clinical specialty.
This is the season that many new Doctor of Pharmacy graduates are accelerating their careers by entering a Residency program or many existing Residents are completing their PGY1 or PGY2 Residencies.
With the announcement that BPS has issued a call for petition for both Cardiology and Infectious Diseases Pharmacy, this edition of the BPS Leadership Blog is a good place to review the overall process for recognizing new specialties.
Ambulatory Care Board Certification: Another Step Forward for Pharmacist-delivered Ambulatory Care Services
The practice of pharmacy in the ambulatory care setting is as old as the profession. Pharmacy practice for the majority of patients outside of the hospital/inpatient care setting is honestly best described by the overarching term ambulatory care.
Over the past 6 years, I have attended meetings of the Council in Credentialing in Pharmacy (CCP) as an observer during my APhA Executive Residency and as a CCP Alternate Director in my past role as Associate Director, Governance at APhA and current role as Director, Professional Affairs at BPS.
In the BPS White Paper 2013 – Five-Year Vision for Pharmacy Specialties, the critical importance of international pharmacy practice to BPS is identified.
Welcome to the first edition of the BPS Leadership Blog. This blog will offer news and insights from members of the BPS Board of Directors on various issues related to the Board Certification of Pharmacists.